Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FCI Effectiveness in NAFLD Stratification

NCT: NCT05827432 · WITHDRAWN

NCT IDNCT05827432
StatusWITHDRAWN
Start Date2026-03
Completion2026-03-26

Brief Summary

The goal of this pilot study is exploring whether field-cycling imaging may be able to detect characteristics of liver disease in patients with different degree of non-alcoholic fatty liver disease (NAFLD) that could be important in reflecting disease progression.

Frequently Asked Questions

What is FCI Effectiveness in NAFLD Stratification?

FCI Effectiveness in NAFLD Stratification is a clinical trial registered under NCT05827432. Current status: WITHDRAWN.

What is the status of NCT05827432?

The current status of NCT05827432 (FCI Effectiveness in NAFLD Stratification) is: WITHDRAWN.

When did FCI Effectiveness in NAFLD Stratification start?

FCI Effectiveness in NAFLD Stratification started on 2026-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.